The report covers forecast and analysis for the equine healthcare market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million). The study includes drivers and restraints for the equine healthcare market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the equine healthcare market on a global level. In order to give the users of this report a comprehensive view on the equine healthcare market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, disease type segment and distribution channel segment are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.



The study provides a decisive view on the equine healthcare market by segmenting the market based on product type, disease type, by distribution channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on product type the market is segmented into drug type, vaccine type, and supplemental feed additives. Based on disease type the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever and others category. Based on distribution channel the market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores and others category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries. This segmentation includes demand for equine healthcare market based on product type, disease type and distribution channel in all the regions and countries.


The report also includes detailed profiles of end players such as Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Sant Animale, Eli Lilly and Company (Elanco), Equine Products U.K. Ltd., Merck Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC, Vetoquinol S.A., Zoetis and Others.


This report segments the global equine healthcare market as follows:


Global Equine Healthcare Market: Product Type Segment Analysis

Drug Type


Anti-Infectives

Anti-Inflammatory

Parasiticides

Others

Vaccine Type


Inactivated

Live Attenuated

Recombinant

Others

Supplemental Feed Additives

Global Equine Healthcare Market: Diseases Segment Analysis

West Nile Virus

Equine Rabies

Equine Influenza

Equine Herpes Virus

Potomac Horse Fever

Others

Global Equine Healthcare Market: Distribution Channel Method Analysis

Veterinary Hospitals And Clinics

Retail Pharmacies And Drug Stores

Others

Global Equine Healthcare Market: Regional Segment Analysis

North America


The U.S.

Europe


UK

France

Germany

Asia Pacific


China

Japan

India

Latin America


Brazil

Middle East and Africa